The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies.

New insights to the workings of a protein that moves neurotransmitters across the nerve cell membrane could aid the design of more effective antidepressants.

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

Laura Dugan strives to bring breakthroughs in neuroscience research and the aging brain together.

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.